Ok_老虎社区_美港股上老虎

Soojj
2021-08-13

Moderna study shows its COVID-19 vaccine holds up against several variants after six months

Moderna Inc. shares ticked higher in the extended session Thursday afetr the biotech drug company sa

Moderna study shows its COVID-19 vaccine holds up against several variants after six months

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":894533477,"tweetId":"894533477","gmtCreate":1628837023099,"gmtModify":1631890349834,"author":{"id":3582029553166690,"idStr":"3582029553166690","authorId":3582029553166690,"authorIdStr":"3582029553166690","name":"Soojj","avatar":"https://static.tigerbbs.com/2c7b0e3654b1b442172ea81a7188cb95","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Ok</p></body></html>","htmlText":"<html><head></head><body><p>Ok</p></body></html>","text":"Ok","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/894533477","repostId":1109187442,"repostType":4,"repost":{"id":"1109187442","kind":"news","pubTimestamp":1628834960,"share":"https://www.laohu8.com/m/news/1109187442?lang=&edition=full","pubTime":"2021-08-13 14:09","market":"us","language":"en","title":"Moderna study shows its COVID-19 vaccine holds up against several variants after six months","url":"https://stock-news.laohu8.com/highlight/detail?id=1109187442","media":"Market Wacth","summary":"Moderna Inc. shares ticked higher in the extended session Thursday afetr the biotech drug company sa","content":"<p>Moderna Inc. shares ticked higher in the extended session Thursday afetr the biotech drug company said a study showed its COVID-19 vaccine held up against several variants of the virus that causes the disease.</p>\n<p>The study was tested against SARS-CoV-2 variants that included alpha, beta, gamma, delta epsilon, and iota, ModernaMRNA,+1.58%said. While the patients given two doses of Moderna COVID-19 vaccine had some “waning in antibody levels,” the majority had enough antibodies to neutralize the virus at the six-month mark, the company said.</p>\n<p>“These data support the durable efficacy of 93% seen with the Moderna COVID-19 vaccine through six months,” said Stéphane Bancel, chief executive of Moderna, in a statement.</p>\n<p>“We expect that these data and the growing body of real-world evidence will help inform health regulators’ approaches to how and when to administer additional boosting doses,” Bancel said.</p>\n<p>Shares rose 0.7% after-hours, following a 1.6% rise in the regular session to close at $391.42. The stock is up 463% over the past 12 months, compared with a 32% gain on the S&amp;P 500 indexSPX,+0.30%.</p>","source":"lsy1604288433698","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna study shows its COVID-19 vaccine holds up against several variants after six months</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna study shows its COVID-19 vaccine holds up against several variants after six months\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 14:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/moderna-study-shows-its-covid-19-vaccine-holds-up-against-several-variants-after-six-months-11628803856?mod=home-page><strong>Market Wacth</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc. shares ticked higher in the extended session Thursday afetr the biotech drug company said a study showed its COVID-19 vaccine held up against several variants of the virus that causes the...</p>\n\n<a href=\"https://www.marketwatch.com/story/moderna-study-shows-its-covid-19-vaccine-holds-up-against-several-variants-after-six-months-11628803856?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.marketwatch.com/story/moderna-study-shows-its-covid-19-vaccine-holds-up-against-several-variants-after-six-months-11628803856?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109187442","content_text":"Moderna Inc. shares ticked higher in the extended session Thursday afetr the biotech drug company said a study showed its COVID-19 vaccine held up against several variants of the virus that causes the disease.\nThe study was tested against SARS-CoV-2 variants that included alpha, beta, gamma, delta epsilon, and iota, ModernaMRNA,+1.58%said. While the patients given two doses of Moderna COVID-19 vaccine had some “waning in antibody levels,” the majority had enough antibodies to neutralize the virus at the six-month mark, the company said.\n“These data support the durable efficacy of 93% seen with the Moderna COVID-19 vaccine through six months,” said Stéphane Bancel, chief executive of Moderna, in a statement.\n“We expect that these data and the growing body of real-world evidence will help inform health regulators’ approaches to how and when to administer additional boosting doses,” Bancel said.\nShares rose 0.7% after-hours, following a 1.6% rise in the regular session to close at $391.42. The stock is up 463% over the past 12 months, compared with a 32% gain on the S&P 500 indexSPX,+0.30%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":122,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}

Moderna study shows its COVID-19 vaccine holds up against several variants after six months

评论（1）

热议股票